Zenas BioPharma (ZBIO) Institutional Ownership

Of the 70 institutional investors that purchased Zenas BioPharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($2.69M), Bank of America Corp DE ($1.58M), Federated Hermes Inc. ($1.56M), Polar Capital Holdings Plc ($1.06M), NEA Management Company LLC ($789.50K), EcoR1 Capital LLC ($789.50K), and Vanguard Group Inc. ($460.85K).

Institutional investors have bought a total of 11,924,809 shares in the last 24 months. This purchase volume represents approximately $353.89M in transactions.

Of the 14 institutional investors that sold Zenas BioPharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: ArrowMark Colorado Holdings LLC ($343.18K), Vivo Capital LLC ($329.77K), Pivotal bioVenture Partners Investment Advisor LLC ($187.05K), Schroder Investment Management Group ($104.28K), Rock Springs Capital Management LP ($78.60K), Eversept Partners LP ($37.73K), and Millennium Management LLC ($22.69K).

Institutional investors have sold a total of 1,153,633 shares in the last 24 months. This volume of shares sold represents approximately $37.03M in transactions.